IR Contacts

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Investor Relations

Stephen Schultz - GW Pharmaceuticals
Vice President, Investor Relations

+1 917.280.2424
sschultz@gwpharm.com

Financial Public Relations Advisor

Ben Atwell / Simon Conway - FTI Consulting
200 Aldersgate | Aldersgate Street
London, EC1A 4HD

+44 (0)20 3727 1000 (Direct)
+1 401.500.6570 (Mobile)
ben.atwell@fticonsulting.com / Simon.Conway@fticonsulting.com

Please submit your question using the form below.

Contact Form
* Indicates required field
http://apps.shareholder.com/captcha/captcha.aspx?verifyid=1900100860&CompanyID=AMDA-1TW341&t=.jpg

Ways to keep up to date with GW